New York State Teachers Retirement System Holds Stake in Bio-Rad Laboratories Inc. (BIO)
New York State Teachers Retirement System continued to hold its stake in Bio-Rad Laboratories Inc. (NYSE:BIO) during the second quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 14,100 shares of the company’s stock at the end of the second quarter. New York State Teachers Retirement System’s holdings in Bio-Rad Laboratories were worth $2,017,000 as of its most recent SEC filing.
Several other large investors also recently bought and sold shares of BIO. State Street Corp raised its stake in Bio-Rad Laboratories by 4.1% in the first quarter. State Street Corp now owns 554,735 shares of the company’s stock worth $75,838,000 after buying an additional 22,053 shares during the period. Meeder Asset Management Inc. raised its stake in Bio-Rad Laboratories by 10,254.5% in the first quarter. Meeder Asset Management Inc. now owns 1,139 shares of the company’s stock worth $156,000 after buying an additional 1,128 shares during the period. Aperio Group LLC raised its stake in Bio-Rad Laboratories by 10.0% in the first quarter. Aperio Group LLC now owns 8,629 shares of the company’s stock worth $1,180,000 after buying an additional 783 shares during the period. JPMorgan Chase & Co. raised its stake in Bio-Rad Laboratories by 113.1% in the first quarter. JPMorgan Chase & Co. now owns 33,379 shares of the company’s stock worth $4,563,000 after buying an additional 17,719 shares during the period. Finally, Renaissance Technologies LLC raised its stake in Bio-Rad Laboratories by 77.8% in the first quarter. Renaissance Technologies LLC now owns 144,900 shares of the company’s stock worth $19,811,000 after buying an additional 63,400 shares during the period. Institutional investors and hedge funds own 62.82% of the company’s stock.
Shares of Bio-Rad Laboratories Inc. (NYSE:BIO) traded up 0.20% on Friday, reaching $161.33. The company had a trading volume of 132,270 shares. Bio-Rad Laboratories Inc. has a 52-week low of $122.03 and a 52-week high of $164.89. The company has a 50-day moving average price of $158.84 and a 200-day moving average price of $148.05. The firm has a market capitalization of $4.75 billion, a PE ratio of 48.93 and a beta of 0.87.
Bio-Rad Laboratories (NYSE:BIO) last announced its earnings results on Wednesday, August 3rd. The company reported $0.61 EPS for the quarter, missing the consensus estimate of $1.13 by $0.52. The business earned $516.80 million during the quarter, compared to analyst estimates of $497.80 million. Bio-Rad Laboratories had a return on equity of 3.86% and a net margin of 4.79%. The firm’s revenue was up 2.1% compared to the same quarter last year. During the same period in the previous year, the firm earned $0.97 earnings per share. Equities research analysts forecast that Bio-Rad Laboratories Inc. will post $3.10 EPS for the current fiscal year.
A number of equities research analysts have recently issued reports on BIO shares. Jefferies Group increased their target price on Bio-Rad Laboratories from $200.00 to $225.00 and gave the company a “buy” rating in a research note on Wednesday, September 7th. Zacks Investment Research upgraded Bio-Rad Laboratories from a “sell” rating to a “hold” rating in a research note on Wednesday, July 6th. Finally, CL King began coverage on Bio-Rad Laboratories in a research note on Wednesday. They issued a “buy” rating and a $180.00 target price for the company.
About Bio-Rad Laboratories
Bio-Rad Laboratories, Inc (Bio-Rad) is a manufacturer and distributor of life science research and clinical diagnostics products. The Company manufactures and supplies the life science research, healthcare, analytical chemistry and other markets with a range of products and systems used to separate complex chemical and biological materials and to identify, analyze and purify their components.
Want to see what other hedge funds are holding BIO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Bio-Rad Laboratories Inc. (NYSE:BIO).
Receive News & Ratings for Bio-Rad Laboratories Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bio-Rad Laboratories Inc. and related companies with MarketBeat.com's FREE daily email newsletter.